SCHEMBL13547799

SCHEMBL13547799

CNC(=O)c1cc(Oc2cccc(/C=C/C(=O)Nc3ccc(CO)c(C(F)(F)F)c3)c2)ccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 4/20 0.58
RAF1 P04049 11/20 0.55
BRAF P15056 9/20 0.55
SRC P12931 3/20 0.54
KDR P35968 7/20 0.53
MAPK14 Q16539 4/20 0.53
MAP3K20 Q9NYL2 4/20 0.53
ABL1 P00519 4/20 0.53
EPHA2 P29317 3/20 0.53
NTRK2 Q16620 3/20 0.53
AURKB Q96GD4 3/20 0.53
EPHX2 P34913 3/20 0.53
TEK Q02763 3/20 0.53
PLK4 O00444 2/20 0.53
AURKA O14965 2/20 0.53
MAPK13 O15264 2/20 0.53
MAP4K4 O95819 2/20 0.53
LCK P06239 2/20 0.53
FYN P06241 2/20 0.53
LYN P07948 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3540263 0.94 RAF1 (0.58) RETRAF1BRAFSRCKDR
SCHEMBL3540267 0.94 RAF1 (0.58) RETRAF1BRAFSRCKDR
SCHEMBL3548061 0.93 RET (0.55) RETRAF1BRAFSRCKDR
SCHEMBL3548057 0.93 RET (0.55) RETRAF1BRAFSRCKDR
SCHEMBL13547812 0.93 RET (0.56) RETRAF1BRAFSRCKDR
SCHEMBL3542434 0.89 RET (0.53) RETRAF1BRAFSRCKDR
SCHEMBL13547810 0.89 SRC (0.64) RETRAF1BRAFSRCKDR
SCHEMBL3542430 0.89 RET (0.53) RETRAF1BRAFSRCKDR
SCHEMBL3544571 0.89 RET (0.74) RETRAF1BRAFSRCKDR
SCHEMBL3544568 0.89 RET (0.74) RETRAF1BRAFSRCKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7652041-B2 4-[4-(3-oxo-3-{[3-(trifluoromethyl)phenyl]amino}propyl)phenoxy]pyridino-2-carboxamido: N-methyl-4-[4-(3-oxo-3-{[3-(trifluoromethyl)phenyl]amino}propyl)phenoxy]pyridine-2-carboxamide: Raf-kinase inhibitors MILLENNIUM PHARMACEUTICALS, INC. (US) 2010-01-26 US disclosed